LAM
CELG

Lebenthal Asset Management’s Celgene Corp CELG Stock Holding History

Lebenthal Asset Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.09M Sell
8,794
-7,244
-45% -$867K 0.14% 203
2016
Q4 		$1.86M Buy
16,038
+52
+0.3% +$5.79K 0.24% 127
2016
Q3 		$1.67M Sell
15,986
-127
-0.8% -$13.7K 0.22% 147
2016
Q2 		$1.59M Buy
+16,113
New +$1.67M 0.21% 156

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lebenthal Asset Management's CELG Position: Q1 2017 in Review

Lebenthal Asset Management reduced its Celgene Corp (CELG) stake by 45% in Q1 2017, selling an estimated $867K and leaving 8,794 shares worth $1.09M. The position accounts for 0.14% of the portfolio, ranked #203.

Lebenthal Asset Management first reported a position in CELG in Q2 2016 and has held it in 4 quarters since. The position peaked at $1.86M in Q4 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • Lebenthal Asset Management held 8,794 shares of Celgene Corp worth $1.09M as of Q1 2017.
  • Lebenthal Asset Management sold 7,244 Celgene Corp shares in Q1 2017, an estimated $867K.
  • Celgene Corp made up 0.14% of Lebenthal Asset Management's portfolio in Q1 2017, its #203 holding.
  • Lebenthal Asset Management first reported a position in Celgene Corp in Q2 2016 and has held it in 4 quarters since.
  • Lebenthal Asset Management's Celgene Corp position peaked at $1.86M in Q4 2016.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Lebenthal Asset Management's 13F filing for Q1 2017, filed 15 May 2017.